Attached files

file filename
EX-31.2 - CERTIFICATION OF THE COMPANY?S CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. - VistaGen Therapeutics, Inc.ex31-2.htm
10-K - FORM 10-K - VistaGen Therapeutics, Inc.vsta10k_mar312015.htm
EX-31.1 - CERTIFICATION OF THE COMPANY?S CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - VistaGen Therapeutics, Inc.ex31-1.htm
EXHIBIT 32
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
Pursuant to 18 U.S.C. § 1350, as created by Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of VistaGen Therapeutics, Inc. (the “ Company ”) hereby certifies, to such officer’s knowledge, that:
 
(i) the accompanying Annual Report on Form 10-K of the Company for the annual period ended March 31, 2015 (the “ Report ”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and
 
(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


June 29, 2015

/s/ Shawn K. Singh
Shawn K. Singh, JD
Principal Executive Officer


/s/ Jerrold D. Dotson
Jerrold D. Dotson
Principal Financial Officer